Introduction {#S1}
============

The optimal treatment strategy for squamous cell carcinoma (SCC) of the larynx is still a matter of debate. Radiotherapy (RT), with or without chemotherapy (CT), open partial laryngectomy (OPL) and endoscopic resection are established options for functional preservation treatment [@R01] [@R02]. Various factors influence the choice of the treatment strategy: primary tumour site, stage and expected results, as well as the expertise of the multidisciplinary team, availability of the service and rehabilitation facilities, along with the patient\'s decision [@R03].

The early clinical stages of supraglottic and glottic cancer that do not require total laryngectomy (most T1-2 N0 cases) [@R01] are usually considered for either conservative surgery (endoscopic resection, OPL with/without neck dissection) or RT. Single-modality treatment with surgery or RT is generally recommended for early-stage disease (stage I or stage II) in order to preserve the other choice in case of recurrence [@R01].

Resectable, advanced-stage glottic and supraglottic primaries are usually managed with a combined modality approach [@R04]^-^[@R06]. If treated with primary surgery, total laryngectomy is typically required [@R01]. However, some authors [@R07]^-^[@R11] recommend an OPL approach even in selected advanced cancers with or without postoperative radiotherapy (PRT). These selected cases often need to resort to PRT, which could add additional risk of late laryngeal toxicity, jeopardizing the expected functional outcome [@R03] [@R09] [@R12].

Furthermore, early-stage laryngeal cancers (T1-2 N0) can be clinically under-staged (16.3%) [@R07] and postoperative adverse pathologic findings might place these cases into a pathologically advanced stage (i.e. early invasion into the thyroid cartilage [@R13] (pT3~tci~), metastatic adenopathies (pN+) with or without extra-capsular extension (ECE) or positive residual margins (R~(+)~) [@R14].

In these situations, the optimal treatment option, whether to transform a conservative approach into immediate total laryngectomy (ITL), or to preserve the organ function by adopting PRT -- CT or a close \"watch and wait\" policy (w&w), is unclear. At present, the most common Head and Neck Cancer (HNC) guideline [@R01] leaves wide freedom of choice among possible therapeutic options (re-excision, RT, RT-CT), and the recommendations regarding the choice of clinical volumes to be targeted and the respective radiation dose to be released are vague.

The aim of this study was to evaluate the opinion of Italian Radiation Oncologists (ROs) and ENTs on PRT ± CT when clinical early-intermediate stage (cT1-T2 or limited T3 conservatively operable with cN0) glottic and supraglottic cancer are pathologically upgraded in consequence of their unfavourable histopathologic prognostic factors (e.g. pT3~tci~, or R~(+)~).

In particular, the following were investigated:

-   suggestions of HNC specialistsregarding the treatment of RL in the presence of the following unfavourable histopathologic prognostic factors: R~(+)~ (margins \< 1 mm) or R~close~ (margins 1-5 mm) [@R15] or pT3~tci~;

-   when neck volumes without metastatic adenopathies need to be targeted in circumstances in which the RL needs to be irradiated;

-   the dose of radiation that ROs recommend for the RL, considering the risk of sequelae are not fully known.

Materials and methods {#S2}
=====================

A multidisciplinary -review board (ROs and ENTs:) approved the online questionnaire that was sent to RO members of the Italian Association of Radiation Oncology AIRO head and neck workgroup (161 ROs), and the ENT members of the Italian Head and Neck Oncologic Society (AIOCC-IHNS) (101 ENTs). The questionnaire focused on the behaviour of different disciplinary specialists facing glottic and supraglottic clinically early-intermediate staged head and neck cancer (T1-T2-and conservatively operable T3 with cN0) after OPLs, when the histological prognostic factors placed these cases into more advanced stages.

The survey was prepared on the SurveyMonkey online interface ([www.SurveyMonkey.com](http://www.SurveyMonkey.com)). Personalized e-mail invitations with direct links to the survey were sent on 9 January 2012. No compensation was offered to respondents. Responses were collected over a 2-month period (until 9 March 2012).

Survey questions {#S2a}
----------------

The survey contained demographic information and 12 multiple-choice questions. The first five questions ([Table I](#T1){ref-type="table"}) regarded respondents\' clinical setting and experience. Questions 6-9 ([Figs. 1](#F1){ref-type="fig"}-[4](#F4){ref-type="fig"}) focused on the therapeutical approach to RL after OPLs in the case of unfavourable prognostic factors regarding T-site (N-site prognostic factors were not considered in these questions). Questions 10-11 ([Fig. 5](#F5){ref-type="fig"}) focused on radiation target volumes (RL ± lymph-nodal areas) in those cases in which the Nsite prognostic factors are considered uncertain in the hypotheses in which the RL needed to be irradiated. The last question ([Fig. 6](#F6){ref-type="fig"}, [Table II](#T2){ref-type="table"})was reserved for ROs in order to know the radiation dose level recommended for RL in the case of R~(+)~ or R~close~ or R~(-)~ or pT3~tci~.

###### 

Respondents\' clinical setting and experience.

  ----------------------------------------------------------------------------------------- ----------- ----------- -------------- ------------------------------------------- --------- -----------------------------------------
  **1. How many years have you been working with Head and Neck Cancer Patients (HNCPs)?**                                                                                                

  **Answer**                                                                                **RO**\     **ENT**\    **Ratio**\     **p[^\*^](#T1FN1){ref-type="table-fn"}**\             
                                                                                            **N (%)**   **N (%)**   **RO%/ENT%**   **0.001**                                             

  a\) Less than 5 years                                                                     18          (16.5%)     1              (2.5%)                                      *6.44*    0.025^§^

  b\) 6-10 years                                                                            35          (32.1%)     7              (17.9%)                                     *1.78*    0.09^§^

  c\) 11-20 years                                                                           36          (33.0%)     12             (30.8%)                                     *1.073*   0.79^§^

  d\) More than 20 years                                                                    20          (18.3%)     19             (48.7%)                                     *0.37*    0.000^§^

  **2. How many HNCPs are taken care of per year in your institution?**                                                                                                                  

  **Answer**                                                                                **RO**\     **ENT**\    **Ratio**\     **p[^\*^](#T1FN1){ref-type="table-fn"}**\             
                                                                                            **N (%)**   **N (%)**   **RO%/ENT%**   **0.03**                                              

  a\) Less than 50                                                                          39          (35.8%)     5              (13.6%)                                     *2.7*     0.009[^†^](#T1FN2){ref-type="table-fn"}

  b\) From 51-100                                                                           37          (33.9%)     17             (44.7%)                                     *0.76*    0.235[^†^](#T1FN2){ref-type="table-fn"}

  c\) From 101-150                                                                          19          (17.4%)     7              (18.4%)                                     *0.95*    0.890[^†^](#T1FN2){ref-type="table-fn"}

  d\) More than 150                                                                         14          (12.8%)     9              (23.7%)                                     *0.54*    0.113[^†^](#T1FN2){ref-type="table-fn"}

  **3. How many HNCPs submitted to conservative laryngectomy do you see per ye**ar?                                                                                                      

  **Answer**                                                                                **RO**\     **ENT**\    **Ratio**\     **p[^\*^](#T1FN1){ref-type="table-fn"}**\             
                                                                                            **N (%)**   **N (%)**   **RO%/ENT%**   **0.22**                                              

  a\) Less than 5                                                                           25          (22.9%)     4              (10.2%)                                     *2.236*   

  a\) 5-10                                                                                  39          (35.8%)     13             (33.3%)                                     *1.073*   

  b\) 11-20                                                                                 26          (23.8%)     11             (28.2%)                                     *0.846*   

  c\) More than 20                                                                          19          (17,4%)     11             (28.1%)                                     *0.618*   

  **4. Do you have a head and neck cancer board (HNCB) in your institution?**                                                                                                            

  **Answer**                                                                                **RO**\     **ENT**\    **Ratio**\     **p[^\*^](#T1FN1){ref-type="table-fn"}**\             
                                                                                            **N (%)**   **N (%)**   **RO%/ENT%**   **0.20**                                              

  a\) Yes                                                                                   93          (85.3%)     36             (92.3%)                                               

  b\) No                                                                                    16          (14.7%)     3              (7.7%)                                                

  **5. Does your HNCB evaluate:**                                                                                                                                                        

  **Answer**                                                                                **RO**\     **ENT**\    **Ratio**\     **p[^\*^](#T1FN1){ref-type="table-fn"}**\             
                                                                                            **N (%)**   **N (%)**   **RO%/ENT%**   **0.33**                                              

  a\) Selected patients (inoperable patients selected by ENT)?                              27          (29.03%)    6              (16.67%)                                    *1.742*   

  b\) All patients before any specific treatment?                                           58          (62.37%)    26             (72.22%)                                    *0.864*   

  c\) Other? (please specify)                                                               8           (8.6%)      4              (11.11%)                                    *0.774*   
  ----------------------------------------------------------------------------------------- ----------- ----------- -------------- ------------------------------------------- --------- -----------------------------------------

Chi-square tests;

Adjusted residuals (cell-by-cell analyses).

![Which course of action do you recommend for the RL in the case of R(+) (margins \< 1 mm) (Question 6).](0392-100X-33-311-g001){#F1}

![Which course of action do you recommend for the RL in the case of R~close~ (margins 1-5 mm) (Question 7).](0392-100X-33-311-g002){#F2}

![Which course of action do you recommend for the RL in the case of R(-) (margins \> 5 mm) (Question 8).](0392-100X-33-311-g003){#F3}

![Which course of action do you recommend for the RL in the case of R(-) but pT3~tci~ (Question 9).](0392-100X-33-311-g004){#F4}

![cNo -- when you are obliged to irradiate the RL for the presence of negative prognostic factors in the tumour site, do you think that in this case the cNo areas should you be irradiated with RL? (Question 10). pNo -- when you are obliged to irradiate the RL for the presence of negative prognostic factors in the tumour site, do you think that in this case the pNo areas should you be irradiated with RL? (Question 11).](0392-100X-33-311-g005){#F5}

![Which radiation dose do you recommend for the laryngeal remnant when radiotherapy is advisable or when the patient refuses immediate total laryngectomy? (doses are expressed in Dose equivalent 2 Gy/ fr.) (Question 12).](0392-100X-33-311-g006){#F6}

Analytical overview {#S2b}
-------------------

Dataset analysis was clusterized into ENTs and ROs for direct comparison.

Statistical analysis {#S2c}
--------------------

Descriptive statistics, Fisher\'s exact tests (Fisher\'s P~(two\ tailed)~) or chi-square tests (P~Chi-square~) were performed using Winpepi software, where appropriate 16. When a significant chi-square association was found, adjusted residuals were calculated to indentify those cells that contributed most to the chi-square. Using the contingency table of Fisher\'s exact tests, the examined specific endpoint (e.g. PRT) was tested against the sum of remaining endpoints (i.e. ITL and w&w policy), considered together with the alternative hypothesis (see [Figs. 1](#F1){ref-type="fig"}-[4](#F4){ref-type="fig"}). Frequencies were automatically calculated by Survey-Monkey.

Results {#S3}
=======

A total of 154 of 262 questionnaires sent (161 to ROs and 101 to ENTs) were filled in (58.8% response rate). Of the 154 respondents, 6 were excluded because they answered only the first three questions, which were concerned only with institutional demographics. Consequently, 148 usable responses (56.4%) were included in the final analysis: 109/161 ROs (respondent RO~(%)~ = 67.7%) and 39/101 ENTs (respondent ENT~(%)~ = 38.6%).

Respondents\' clinical setting and experience ([Table I](#T1){ref-type="table"}) {#S3a}
--------------------------------------------------------------------------------

Respondents represented a variety of working settings: primarily exploiting activity in non-academic hospitals (58%), academic hospitals (25%), and private institutions (17.0%). Most respondents (87.2%) had a HNC-board (HNCB) in their institution. Particularly, 65.1% of respondents evaluated all patients before any specific treatment within their HNCB, while 34.9% evaluated only selected patients (inoperable patients selected by ENTs or patients who did not meet institutional guidelines). Among those who answered the questionnaire, 31/39 ENTs (79.5%) vs. 56/109 ROs (51.4%) had more than 10 years\' experience working with HNC patients (Fisher\'s P~(two\ tailed)~ = 0.002) (see details in [Table I](#T1){ref-type="table"}, Question 1). Conversely, more ROs than ENTs worked in institutions with less than 50 HNCPs per year (see details in [Table I](#T1){ref-type="table"}; Question 2). Finally, considering the numbers of HNCPs submitted to OPL per year seen for each specialist ([Table I](#T1){ref-type="table"}, Question 3) there was no statistically difference (P~Chi-square~ = 0.22) between the two specialist groups.

When does the remnant larynx need further treatment? ([Figs. 1](#F1){ref-type="fig"}-[4](#F4){ref-type="fig"}) {#S3b}
--------------------------------------------------------------------------------------------------------------

The clinical scenario of T-site prognostic factors (with no consideration of lymph-nodal prognostic factors) is shown in [Figs. 1](#F1){ref-type="fig"}-[4](#F4){ref-type="fig"}. In the case of R~(+)~ after OPL ([Fig. 1](#F1){ref-type="fig"}, Question 6), the majority of specialists recommended RT, with no significant statistically difference between the two specialist groups (p = 0.60). However, ROs more frequently would add CT to RT (RO~(%)~/ENT~(%)~ = 3.27). In the case of R~close~ ([Fig. 2](#F2){ref-type="fig"}, Question 7), the opinions between the two specialist groups were statistically different (p = 0.000047) since more ROs recommended RT ± CT, while a higher ENT~(%)~ recommended a w&w policy (p = 0.000029). In the case of R~(-)~ disease ([Fig. 3](#F3){ref-type="fig"}, Question 8), the majority of both specialist groups would recommend a w&w policy. Finally, in the case of pT3~tci~ ([Fig. 4](#F4){ref-type="fig"}, Question 9) a higher RO~(%)~ advised RT ± CT (p = 1.3 E-7), while a higher ENT~(%)~ advised a w&w approach (p = 0.000028).

When do neck volumes need to be targeted? ([Fig. 5](#F5){ref-type="fig"}) {#S3c}
-------------------------------------------------------------------------

Two scenarios in which the RL needed to be irradiated (considering Tsite unfavourable prognostic factors) were provided for: first in which the neck was not dissected with clinical negative metastatic lymph-nodes (cNo) and second in which elective neck dissections did not reveal metastatic lymph nodes (pNo). In the former scenario, 64.7% of ROs recommended irradiating both cNo areas and RL, while in the latter the majority of RO recommended irradiating only the RL. The attitude of ENTs was not statistically different for the two scenarios (p = 0.132) ([Fig. 5](#F5){ref-type="fig"}).

Which doses are more frequently recommended on remnant larynx? ([Fig. 6](#F6){ref-type="fig"}, [Table II](#T2){ref-type="table"}) {#S3d}
---------------------------------------------------------------------------------------------------------------------------------

###### 

Which radiation dose do you recommend to the laryngeal remnant when radiotherapy is advisable or when the patient refuses immediate total laryngectomy? (Question 12) (see also [Fig. 6](#F6){ref-type="fig"}).

  --------------------------------------------------------------------------------------------------------------------------
  Answer Options                                      Not recommended   \< 56\   56-60\   62-66\   \> 66\   Response Count
                                                                        Gy       Gy       Gy       Gy       
  --------------------------------------------------- ----------------- -------- -------- -------- -------- ----------------
  \- R+ (margins \< 1 mm)                             4                 1        15       54       29       103

  \- R-close (margins 1- 5 mm)                        17                11       30       32       11       101

  \- Ro (margins \> 5 mm)                             70                6        19       5        1        101

  \- Ro (in patients with cartilage invasion- p T3)   27                15       34       20       4        100

  *answered question*                                                                                       103

  *skipped question*                                                                                        6
  --------------------------------------------------------------------------------------------------------------------------

[Fig. 6](#F6){ref-type="fig"} shows the dosage recommended by 103/109 RO respondents.

Discussion {#S4}
==========

This study attempted to compare the points of view of ROs and ENTs concerning a relatively new question on the postoperative approach to OPL. To our knowledge, this is the first nationwide survey on this topic. Data from literature are only retrospective and thy come from mono- or bi-institutional studies [@R03] [@R08]^-^[@R12] [@R17] [@R18] ([Table III](#T3){ref-type="table"}). The most reported late toxicities are severe oedema condritis (7%) [@R12], radionecrosis (5.5%) [@R12], aspiration and pneumonia (29.4%) [@R11] and toxic death (4%) [@R17] ([Table III](#T3){ref-type="table"}).

###### 

Tissue tolerance in the case of open neck conservative laryngectomy plus postoperative radiotherapy.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                     Pts                                             Surgery                                 RT technique          Remnant larynx average dose   Neck dose      Late toxicity                           Interrupted PRT                              Severe complications                                                     Permanent sequel                                               Toxic death                  Dose evaluated as at risk of complication
  -------------------------- ----------------------------------------------- --------------------------------------- --------------------- ----------------------------- -------------- --------------------------------------- -------------------------------------------- ------------------------------------------------------------------------ -------------------------------------------------------------- ---------------------------- -------------------------------------------
  Robbins 1988 [@R17]        25                                              Horizontal supraglottic laryngectomy    2D-RT                 Not reported                  Not reported   8/25 (32%)                                                                           Prolonged feeding tube (2/25; 8%)\                                       Tracheostomy (2/25; 8%)                                        Pneumonia\                   NR
                                                                                                                                                                                                                                                                             Aspiration with pneumonia (4/25; 16%)                                                                                                   (1/25; 4%)                   

  Spaulding CA 1989 [@R10]   23                                              Standard supraglottic laryngectomy\     2D-RT                 50-61 Gy                      50-61 Gy                                                                                            Lymphoedema neck\                                                        Laryngectomy (1/23)                                            None                         NR
                                                                             Extended supraglottic laryngectomy\                                                                                                                                                             Arytenoid oedema resolved after several months                                                                                                                       
                                                                             Extended vertical laryngectomy                                                                                                                                                                                                                                                                                                                                       

  Lee 1990 [@R08]            50\                                             Horizontal supraglottic laryngectomy    2D-RT                 55 Gy                         63 Gy          NA (mixed to non irradiated patients)   Interruption for arytenoid swelling (1/60)   Prolonged feeding gastrostomies (7/50; -14%)\                            Laryngectomy (3/50) (6%)\                                      3 death                      NR
                             (+10 not irradiated)                                                                                                                                                                                                                            Pneumonia 3%                                                             Tracheostomy 2%                                                                             

  Steiniger 1997 [@R11]      17\                                             Horizontal supraglottic laryngectomy\   2D-RT\                59.30 Gy\                     45.10 Gy\                                              1 patient not compliant                      The average time of decannulation 14.3 w (*vs.* 6.8 w no RT; p = 0.18\   Temporary feeding tube n = 6 (35.2%) (*vs.* 0/12) p = .026\    1 fatal respiratory arrest   NR
                             (*vs.* 12 without postoperative radiotherapy)   1 extended to the tongue base HSGL      4-6 MV\               (50.4-66 Gy)                  (40-50 Gy)                                                                                          To develop adequate oral intake 34.8 w (*vs.* 7.5 w of no RT)\           4 permanent tracheostomy (23.5%) *vs.* 0/12 no RT (p = 0.10)                                
                                                                                                                     LINAC\                                                                                                                                                  Acute upper air respiratory in 5 (29.4%) pts (*vs.* = 0; p \< 0.05)\                                                                                                 
                                                                                                                     60Co beam                                                                                                                                               Pneumonia in 7 patients (29.4%) *vs.* 1/12 no RT (8.3%) (P = 0.18)                                                                                                   

  Laccourreye 2000 [@R12]    90                                              Standard supraglottic laryngectomy\     2D RT\                51.2 Gy\                      50.6 Gy\       15/90 (16.6%)                           (5 = 5.5%) (40 Gy)                           Laryngeal radionecrosis 5/90 (5.5%)\                                     Gastrostomy 3/90 (3%)\                                         3 (3.3%)                     60 Gy (univariate p = 0.014)
                                                                             Supracricoid partial laryngectomy       60Co beam             (25-71)                       (22-70)                                                                                             Laryngeal stenosis 4/90 (4.4%)\                                          Tracheostomy (1/90) (1.1%)                                                                  
                                                                                                                                                                                                                                                                             Aspiration pneumonia 3/90 (3.3%)\                                                                                                                                    
                                                                                                                                                                                                                                                                             Skin necrosis (3.3%)\                                                                                                                                                
                                                                                                                                                                                                                                                                             Oesophageal inlet stenosis 2/90 (2.2%)                                                                                                                               

  Spriano 2000 [@R14]        56                                              Standard supraglottic laryngectomy\     2D RT-60Co beam\      50 Gy                         46 Gy          30/56 (54%)                                                                          Severe oedema/chondritis (7%)\                                           Tracheostomy (1/56) (2%)                                       None                         \> 50 Gy (HR = 2.2)
                                                                             Extended supraglottic laryngectomy      2D RT- 6MV LINAC                                                                                                                                        Laryngeal necrosis (1%)\                                                                                                                                             
                                                                                                                                                                                                                                                                             Persistent aspiration (9%)\                                                                                                                                          
                                                                                                                                                                                                                                                                             Fistula (2%)                                                                                                                                                         

  Oksuz 2008 [@R18]          79                                              Horizontal supraglottic laryngectomy\   2D RT-60Cobalt beam   50 Gy\                        50 Gy          22/79 (27.8%)                                                                        Laryngeal oedema (17/79-21.5%)\                                          Definitive laryngectomy (1/79-1.3%)\                           None                         NA
                                                                             Extended supraglottic laryngectomy                            (48-70 Gy)                                                                                                                        Aspiration/dysphagia (6/79-7.5%)                                         Definitive tracheostomy (3/79 -3.7%)                                                        

  Garibaldi 2009 [@R03]      36                                              Horizontal supraglottic laryngectomy\   2D RT- 6MV LINAC\     59.5 Gy\                      50.4 Gy\       21/32 (65.6%)                                                                        Temporary feeding tube (3.1%)\                                           Tracheostomy (1/32) (3.2%)                                     None                         54.9 Gy (estimated)\
                                                                             Extended supraglottic laryngectomy\     3DCRT                 (45-70.2)                     (39.6-55.8)                                                                                         Temporary tracheostomy (3.1%)\                                                                                                                                       (50.4-55.8)
                                                                             Fronto-lateral laryngectomy\                                                                                                                                                                    Severe neck induration (3.1%)\                                                                                                                                       
                                                                             Other                                                                                                                                                                                           Whispered speech (1%)\                                                                                                                                               
                                                                                                                                                                                                                                                                             Definitive tracheostomy (3.1%)                                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Indeed, the modern approach of OPL has reached prominence in the clinical field only in recent years, and different conservative laryngectomy procedures have been adopted for different extensions of tumour [@R19]. Recently, a systematic review of retrospective mono-institutional studies [@R20] in the English language literature has given more credence to the oncologic efficacy and reliable function preservation of these procedures considering the high local control (90%) reported in over 5000 patients and the high larynx preservation rate (91%) in over 3000 patients. However, Thomas [@R20] reported that approximately 22% of the patients (1151 of 5196) did not have a T-stage available. Thus, blurred stage selections, surgical technique and postoperative care represent challenges that nowadays limit OPL to specific expertise to ensure reproducible results.

Specifically, this new scenario generated some concerns among ROs because of the limited amount of data on this subject [@R03] [@R08] [@R09] [@R12] ([Table III](#T3){ref-type="table"}), and in particular concerning the radiation tolerance of RL after OPL. Nevertheless, information concerning the risk of toxicity is lacking in a comprehensive evaluation of the risk-benefit balance, while PRT is suggested by some Authors to improve local control [@R07].

At the same time, the possibility to reserve a rescue total (or sometimes partial) laryngectomy without survival detriment can drive physicians\' opinion towards a w&w policy when unpredicted, unfavourable prognostic factors are found in the pathological specimen [@R21]. Indeed, in our survey a higher ENT~(%)~ advised a w&w policy in case of R~close~ or pT3~tci~ ([Figs. 2](#F2){ref-type="fig"}, [4](#F4){ref-type="fig"}).

In addition, the recent introduction in radiation oncology practice of modern intensity modulated radiotherapy (IMRT), allowing for conformal RT adaptation to irregular neck shape helps to spare organ function and critical tissues (e.g. resected larynx) from high radiation dosages. This opportunity is raising interest for PRT [@R22].

This expectation could explain the higher percentage of ROs\' responses (67.8%) *vs.* ENTs (38.6%) (RO(%)/ ENT(%) = 1.76), tending to testify a higher concern among ROs.

With regards to the Italian-HNC specialists\' attitude towards the T-site prognostic factors, the results describe substantial agreement both in not using PRT in R~(-)~ patients and in using it in R~(+)~. Their opinions diverge in the case of R~close~ and pT3~tci~ ([Figs. 2](#F2){ref-type="fig"}, [4](#F4){ref-type="fig"}). Indeed, in these cases ROs advise RT more frequently. In contrast, ENTs more frequently suggest a w&w policy in R~close~ and pT3~tci~ cases. However, in the case of R~(+)~, the majority of ROs recommended adding CT to RT, while the majority of ENTs did not recommend it ([Fig. 1](#F1){ref-type="fig"}, Question 6). The discussion of this item brought about an interesting question among the Authors of the present study: does the positive margin of an early-stage tumour in a conservative scenario have the same negative prognostic significance of the positive margin in an advanced-stage tumour in a non-conservative scenario? It is possible that the majority of ENTs did not add CT to RT because they attributed a less negative prognostic meaning to early-stage positive margins.

Regarding radiation volumes (Questions 10 and 11), comments were gathered from both specialist groups\' questionnaires (ROs = 9; ENTs = 7) concerning the fact that the questions did not specify the T-stage and/or the T-site (glottis or supra-glottis) contexts. With these limits in mind, the evaluation of responses to two questions permit us to conclude that in the case of cNo both specialist groups would recommend RT both on the undissected neck and the RL whenever the latter needed to be irradiated. This trend is reversed in the case of pNo where only RL irradiation is more often recommended ([Fig. 5](#F5){ref-type="fig"}, Questions 10-11).

Finally, the questionnaire asked ROs to specify the advised radiation dose on the RL. As shown in [Fig. 1](#F1){ref-type="fig"}, a 62-66 Gy dosage was more frequently recommended in R~(+)~ patients, and 56-60 Gy in the case of pT3~tci~. The recommendations were substantially equally split between 56-60 Gy (29.7%) and 62-66 Gy (31.7%) in the case of R~close~. However, the trend was to advise doses higher than those usually recommended [@R23] [@R24]. Actually, authors from MDACC, Texas [@R23] and Ann-Arbor Hospital, Michigan [@R24] suggest limiting tolerance doses to RL after a horizontal supraglottic laryngectomy up to 55.8 Gy to conserve larynx function. Garden [@R23] recommend treating the larynx to 60 Gy in the rare cases in which positive margins are encountered, and Laccourreye [@R12] does not recommend radiation on RL with negative margins as he reported chondroradionecrosis and/or laryngeal stenosis in 6 negativemargin- T3 patients in his retrospective study. Thus, the pros and cons of PRT need to be studied further.

To our knowledge, only 3 studies [@R03] [@R09] [@R12] have provided a relationship between delivered dose to RL and the risk of radiation-induced complications ([Table II](#T2){ref-type="table"}): their estimation ranges from 50 Gy to 60 Gy. However, the substantial pitfalls of these studies are that they are retrospective, mono/double-institutional and heterogeneous in evaluation methodology.

Our study has some limitations since it is an opinionbased survey with mainly motivated respondents, and thus it might not reflect actual clinical practice in Italy.

In addition, the need to keep the questionnaire short in order to encourage respondents to fill it in limited the clarity of some questions. As mentioned above, it would have been useful to specify: the primary site (glottic or supraglottic), to define margins to be considered diseasefree based on the relative anatomical site (either glottis [@R25] or supraglottic [@R26]), and to better define the clinical stage in each scenario. Furthermore, the survey was limited to OPL and did not consider trans-oral approaches. Nevertheless, to our knowledge, this study is the first to gather the opinions of ROs and ENTs from two national scientific societies (AIRO and AIOCC-IHNS) concerning RT indications after OPL. Taking into account the modern concepts of function-sparing laryngectomy and latest radiation technology, this topic will probably be increasingly important in institutional HNCB multidisciplinary debates.

Conclusions {#S5}
===========

This Italian survey of 109 ROs and 39 ENTs shows that:

-   both specialist groups would recommend PRT in the case of R~(+)~ disease, but most ROs would add chemotherapy. Most ROs (52.4%) recommend 62-66 Gy;

-   in the case of R~close~ or pT3~tci~, while ENTs prefer a w&w policy, the majority of ROs prefer RT with a dose of 56-60 Gy (29.7%) -- 62-66 Gy (31.7%) in the case of R~close~ or 56-60 Gy (34%) in the case of pT3~tci~;

-   neither specialist groups would recommend PRT in the case of R~(-)~ disease, but both would recommend RT for undissected cN0 neck when RT is indicated for the RL.

The issues dealt with in this survey call for renewed attention and prospective studies, considering the introduction of the unique combination of function-sparing laryngectomy concepts in clinical practice and the latest IMRT-techniques allowing for selective target volume irradiation.

Laurence Preston revised the English text of the manuscript. The authors thank the 161 oncologists who answered the questionnaire. This study was partly supported by \"Lega italiana per la cura contro i tumori - Sezione di Cuneo\".
